Cardiometabolic Medical Representative

Israel

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess strong leadership and business ownership skills, with the ability to articulate a unique value proposition and identify critical care gaps. A deep understanding of the healthcare marketplace, payer environment, customer priorities, patient and product flows, disease states, therapeutic options, and company resources, processes, policies, and procedures is essential. The role requires the ability to analyze flows, prioritize opportunities, build territory and account plans, and secure resources.

Responsibilities

The Cardiometabolic Medical Representative will develop and implement territory-specific plans based on customer priorities and market trends, assessing results and adjusting strategy to maximize impact. They will champion the product's value proposition to healthcare professionals (HCPs) and articulate unmet needs to optimize patient care pathways. The representative will achieve and exceed sales objectives through personalized engagements, virtual outreach, and digital tactics, utilizing an omnichannel approach. They must also demonstrate clinical expertise in disease states and treatment regimens, craft and execute account strategies to facilitate product adoption, and collaborate with cross-functional teams. Maintaining compliance with all ethical guidelines is also a key responsibility.

Skills

Sales

Account Management

Strategic Thinking

Healthcare Market Analysis

Payer Environment Understanding

Customer Engagement

Territory Planning

Consultative Sales

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free